Celebrex Goes Before The FDA Today
Today is the start of the 3 days of hearings by the FDA for the COX2 Inhibitors, Celebrex and Bextra.
The Food and Drug Administration promised prompt action Wednesday on recommendations from
advisory committees probing the safety of popular painkillers, but urged the
advisers to balance the risks and benefits of the drugs.
The FDA says it will take action with a couple weeks of the recommendations. So if they pull it I will have 2 weeks to see my doctor and have that unwanted discussion with him. Right now I am not having positive feelings about this whole thing. It does seem that they will take into consideration the benefits of it though.
Galson reminded the group that the drugs in question are important painkillers widely used by people in chronic pain. It is important to balance the risks of drugs with their benefits, he said.